ATLASEnsysce Biosciences (ENSC) earnings date: Nov 13, 2026
Ensysce Biosciences (ENSC) reports earnings for the quarter ended Sep 30, 2026 on Fri, Nov 13, 2026. Analysts expect EPS of -$0.19.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on ENSC
| Last price | $0.42 (-3.9%) |
|---|---|
| Normal 1-day range (±1σ) | ±5.5% |
| Earnings beat history | Beat the EPS estimate in 4 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Ensysce Biosciences stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Ensysce Biosciences reports on Nov 13, 2026. One email the day before, with ATLAS’s read on Ensysce Biosciences. You can switch it off at any time.
Alert me before ENSC reportsFree to start. Creating an account takes under a minute.
ENSC earnings at a glance
| Next report (confirmed) | Fri, Nov 13, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.19 |
| Last report | Aug 13, 2026 · Beat |
| Beat rate (last 5 reports) | 4 of 5 (80%) |
| Average EPS surprise | +31.4% |
| Average move around a report | ±5.2% (last 5) |
| Sector | Healthcare · Biotechnology |
Ensysce Biosciences earnings history: last 5 reports
Ensysce Biosciences last reported on Aug 13, 2026: EPS of -$0.20 against an estimate of -$0.50 (+60.0% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 13, 2026 | -$0.50 | -$0.20 | +60.0% | Beat | +0.3% |
| May 15, 2026 | -$0.73 | -$0.52 | +28.8% | Beat | +14.4% |
| Mar 30, 2026 | -$1.26 | -$0.75 | +40.5% | Beat | +2.1% |
| Dec 3, 2025 | $0.27 | $0.45 | +66.7% | Beat | +4.2% |
| Nov 14, 2025 | -$0.93 | -$1.29 | -38.7% | Miss | -5.3% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for ENSC
See the fair value, the probability range and the earnings history of Ensysce Biosciences on its ATLAS page.
Ensysce Biosciences (ENSC) stock analysisPlans from €3.99 a month.
Ensysce Biosciences earnings: frequently asked questions
When does Ensysce Biosciences (ENSC) report earnings?
Ensysce Biosciences is scheduled to report on Friday, November 13, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for ENSC?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.19 per share (USD). Estimates can change before the report.
How often does ENSC beat earnings estimates?
Of its last 5 reports with a recorded result, Ensysce Biosciences beat the EPS estimate 4 times; the average surprise was +31.4%. Past results do not predict the next one.
How much does ENSC move around earnings?
Over its last 5 reports the stock moved an average of 5.2% (absolute, from the close before the report day to the close after it), and finished higher 4 of 5 times.
Did Ensysce Biosciences beat earnings estimates last quarter?
Ensysce Biosciences last reported on Aug 13, 2026: EPS of -$0.20 against an estimate of -$0.50 (+60.0% surprise), a beat.
How much does ENSC usually move in a day?
On a normal trading day the ATLAS model puts ENSC’s one-day range at about ±5.5%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Fri, Nov 13, 2026
Educational information, not investment advice. Disclaimer